Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.45 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.34 |
| ▸ | ACACB | O00763 | 1/20 | 0.34 |
| ▸ | ACACA | Q13085 | 1/20 | 0.34 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.34 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.34 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.34 |
| ▸ | MMP2 | P08253 | 2/20 | 0.34 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16074911 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074711 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074892 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074763 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074748 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074860 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074864 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074793 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074851 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA | |
| SCHEMBL16074946 | 0.97 | PTPN1 (0.48) | PTPN1THRBFFAR4ACACBACACA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260076803-A1 | POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | INNOVIA, INC. (US) | 2026-03-19 | — | — | US | claimed |
| WO-2024015200-A1 | POLYISOBUTYLENE‐BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | PINCHUK LEONARD (US) | 2024-01-18 | — | — | WO | claimed |
| CN-113993715-B | Transfer sheet | 株式会社爱赛璐 | 2023-08-29 | — | — | CN | claimed |
| EP-4504883-B1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | PROCTER & GAMBLE (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20260076803-A1 | POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | INNOVIA, INC. (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4504883-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | The Procter & Gamble Company (US) | 2025-02-12 | — | — | EP | disclosed |
| US-12214618-B2 | Transfer sheet | AICELLO CORPORATION (JP) | 2025-02-04 | — | — | US | disclosed |
| EP-4463534-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | The Procter & Gamble Company (US) | 2024-11-20 | — | — | EP | disclosed |
| WO-2023196452-A1 | FABRIC TREATMENT COMPOSITIONS WITH ANTIOXIDANT MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-10-12 | — | — | WO | disclosed |
| CN-113993715-B | Transfer sheet | 株式会社爱赛璐 | 2023-08-29 | — | — | CN | disclosed |
| WO-2023137409-A1 | TREATMENT COMPOSITIONS WITH MODIFIED AMINO ACID MULTIMERS | THE PROCTER & GAMBLE COMPANY (US) | 2023-07-20 | — | — | WO | disclosed |
| EP-0116309-A1 | Flexible polyurethane foams having high indentation load deflection prepared from polyol blends | BASF WYANDOTTE CORPORATION (US) | 1984-08-22 | — | — | EP | disclosed |
| EP-0114072-A2 | Delayed co-initiation process for preparing polyol blends | BASF Corporation (US) | 1984-07-25 | — | — | EP | disclosed |
| US-4332953-A | FOR PREPARING URETHANE FOAMS AND ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1982-06-01 | — | — | US | disclosed |
| US-4331809-A | INTERMEDIATES FOR PREPARING POLYURETHANE FOAMS AND ELASTOMERS | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4331810-A | Carbamylbiuret-modified polyisocyanates | BASF WYANDOTTE CORPORATION (US) | 1982-05-25 | — | — | US | disclosed |
| US-4330636-A | Carbamylbiuret-modified polyisocyanates | BASF WYANDOTTE CORPORATION (US) | 1982-05-18 | — | — | US | disclosed |
| US-4271087-A | WHICH CAN ALSO CONTAIN GUANIDINE LINKAGES AND THIOUREA LINKAGES | BASF WYANDOTTE CORPORATION (US) | 1981-06-02 | — | — | US | disclosed |
| US-4151204-A | REACTION OF A DIHYDROXY ALCOHOL AND AMMONIA USING A HYDROGENATION CATALYST | TEIJIN LIMITED (JP) | 1979-04-24 | — | — | US | disclosed |
| US-4062900-A | OR BUTENEDIOLHYDROLYZING DIACETOXY-BUTANE OR BUTENE | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1977-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260076803-A1 | POLYISOBUTYLENE-BASED POLYURETHANES FOR MEDICAL IMPLANT DEVICES | TNNC1, TNNI3, MYLK2 | PTPN1 4785/4885THRB 2072/4885SMN1; SMN2 1931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.